Human HNRNPA2B1 knockout HEK293T cell line
Abcam plcKnockout achieved by using CRISPR/Cas9, Homozygous: 2 bp deletion in exon 3
Products, services, reviews and techniques used in the preliminary investigations of the disease; the cell biology, genetics and protein pathways using tissue culture, cloning and imaging.
Knockout achieved by using CRISPR/Cas9, Homozygous: 2 bp deletion in exon 3
Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon 2 and 5 bp deletion in exon 2
Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp insertion in exon 1
Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp deletion in exon 2
Knockout achieved by using CRISPR/Cas9, 10 bp deletion in exon 12 and 1 bp deletion in exon 12 and 4 bp deletion in exon 12
Knockout achieved by using CRISPR/Cas9, Homozygous: 8 bp deletion in exon 2
Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp insertion in exon 6
Knockout achieved by using CRISPR/Cas9, Homozygous: Insertion of the selection cassette in exon 2
Knockout achieved by using CRISPR/Cas9, Homozygous: Insertion of the selection cassette in exon 3
Knockout achieved by using CRISPR/Cas9, Homozygous: 11 bp deletion in exon 2